Literature DB >> 23183171

IGF-I 3' untranslated region: strain-specific polymorphisms and motifs regulating IGF-I in osteoblasts.

Spenser S Smith1, Catherine B Kessler, Vikram Shenoy, Clifford J Rosen, Anne M Delany.   

Abstract

Reduced IGF-I is associated with low bone mass in humans and mice. C3H/He/J (C3H) mice have higher skeletal IGF-I and greater bone mass than C57BL/6J (B6). We hypothesized that strain-related genotypic differences in Igf1 affected skeletal function. The Igf1 coding region is nonpolymorphic, but its 3' untranslated region (UTR) is polymorphic between C3H and B6. Luciferase-Igf1 3' UTR reporter constructs showed that these polymorphic regions did not affect UTR function. IGF-I splice variants give rise to a common mature IGF-I peptide, but different E peptides. We identified two splice products, exon 4+6 (Ea) and exon 4+5+6 (Eb, mechano-growth factor) and found that their abundance was unchanged during osteoblastic differentiation. The Igf1 3' UTR encoded by exon 6 contains alternative polyadenylation sites. Proximal site use produces a short 3' UTR of approximately 195 bases, whereas distal site usage results in an approximately 6300-base UTR. Although Igf1 mRNA levels did not change during osteoblastic differentiation, distal polyadenylation site usage was increased in B6 cells but not in C3H. The resulting long Igf1 RNA isoform is less stable and has decreased translation efficiency, which may be one mechanism contributing to decreased IGF-I in B6 vs. C3H mice. Although the long UTR contains a conserved [GU](18) repeat, which is a positive regulator of UTR activity, it is also targeted by negative regulators, miR-29 and miR-365. These microRNAs are increased in B6 and C3H cells during osteoblastic differentiation. Differential expression of the long Igf1 3' UTR isoform may be a possible mechanism for enhanced IGF-I regulation in B6 vs. C3H mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23183171      PMCID: PMC3529377          DOI: 10.1210/en.2012-1476

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  59 in total

1.  miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.

Authors:  Seong-Yeon Park; Jung Hyun Lee; Minju Ha; Jin-Wu Nam; V Narry Kim
Journal:  Nat Struct Mol Biol       Date:  2008-12-14       Impact factor: 15.369

2.  Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation.

Authors:  Zhaoyong Li; Mohammad Q Hassan; Mohammed Jafferji; Rami I Aqeilan; Ramiro Garzon; Carlo M Croce; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  J Biol Chem       Date:  2009-04-02       Impact factor: 5.157

3.  Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.

Authors:  Qun Pan; Ofer Shai; Leo J Lee; Brendan J Frey; Benjamin J Blencowe
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

4.  Rapid and systematic analysis of the RNA recognition specificities of RNA-binding proteins.

Authors:  Debashish Ray; Hilal Kazan; Esther T Chan; Lourdes Peña Castillo; Sidharth Chaudhry; Shaheynoor Talukder; Benjamin J Blencowe; Quaid Morris; Timothy R Hughes
Journal:  Nat Biotechnol       Date:  2009-06-28       Impact factor: 54.908

5.  miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling.

Authors:  Kristina Kapinas; Catherine B Kessler; Anne M Delany
Journal:  J Cell Biochem       Date:  2009-09-01       Impact factor: 4.429

6.  The insulin-like growth factor (IGF)-I E-peptides modulate cell entry of the mature IGF-I protein.

Authors:  Lindsay A Pfeffer; Becky K Brisson; Hanqin Lei; Elisabeth R Barton
Journal:  Mol Biol Cell       Date:  2009-07-15       Impact factor: 4.138

7.  The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study.

Authors:  Fernando Rivadeneira; Jeanine J Houwing-Duistermaat; Thomas J Beck; Joop A M J L Janssen; Albert Hofman; Huibert A P Pols; Cornelia M Van Duijn; Andre' G Uitterlinden
Journal:  J Bone Miner Res       Date:  2004-04-12       Impact factor: 6.741

8.  NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.

Authors:  Huating Wang; Ramiro Garzon; Hao Sun; Katherine J Ladner; Ravi Singh; Jason Dahlman; Alfred Cheng; Brett M Hall; Stephen J Qualman; Dawn S Chandler; Carlo M Croce; Denis C Guttridge
Journal:  Cancer Cell       Date:  2008-11-04       Impact factor: 31.743

9.  Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: a functional genomics approach.

Authors:  H-L Wong; W-P Koh; N M Probst-Hensch; D Van den Berg; M C Yu; S A Ingles
Journal:  Gut       Date:  2008-02-28       Impact factor: 23.059

10.  Alternative isoform regulation in human tissue transcriptomes.

Authors:  Eric T Wang; Rickard Sandberg; Shujun Luo; Irina Khrebtukova; Lu Zhang; Christine Mayr; Stephen F Kingsmore; Gary P Schroth; Christopher B Burge
Journal:  Nature       Date:  2008-11-27       Impact factor: 49.962

View more
  14 in total

1.  Acute suppression of insulin resistance-associated hepatic miR-29 in vivo improves glycemic control in adult mice.

Authors:  Yu-Han Hung; Matt Kanke; C Lisa Kurtz; Rebecca Cubitt; Rodica P Bunaciu; Ji Miao; Liye Zhou; James L Graham; M Mahmood Hussain; Peter Havel; Sudha Biddinger; Phillip J White; Praveen Sethupathy
Journal:  Physiol Genomics       Date:  2019-06-28       Impact factor: 3.107

2.  Post-transcriptional regulation in osteoblasts using localized delivery of miR-29a inhibitor from nanofibers to enhance extracellular matrix deposition.

Authors:  Eric N James; Anne M Delany; Lakshmi S Nair
Journal:  Acta Biomater       Date:  2014-05-09       Impact factor: 8.947

Review 3.  MicroRNA in myogenesis and muscle atrophy.

Authors:  Xiaonan H Wang
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-05       Impact factor: 4.294

Review 4.  Minireview: mechanisms of growth hormone-mediated gene regulation.

Authors:  Dennis J Chia
Journal:  Mol Endocrinol       Date:  2014-05-13

5.  MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways.

Authors:  Zhaoyong Hu; Janet D Klein; William E Mitch; Liping Zhang; Ivan Martinez; Xiaonan H Wang
Journal:  Aging (Albany NY)       Date:  2014-03       Impact factor: 5.682

6.  miR-365 Ameliorates Dexamethasone-Induced Suppression of Osteogenesis in MC3T3-E1 Cells by Targeting HDAC4.

Authors:  Daohua Xu; Yun Gao; Nan Hu; Longhuo Wu; Qian Chen
Journal:  Int J Mol Sci       Date:  2017-05-04       Impact factor: 5.923

7.  Anabolic effects of IGF-1 signaling on the skeleton.

Authors:  Candice G T Tahimic; Yongmei Wang; Daniel D Bikle
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-04       Impact factor: 5.555

Review 8.  Mega roles of microRNAs in regulation of skeletal muscle health and disease.

Authors:  Mridula Sharma; Prasanna Kumar Juvvuna; Himani Kukreti; Craig McFarlane
Journal:  Front Physiol       Date:  2014-06-26       Impact factor: 4.566

9.  Pathway analysis of microRNA expression profile during murine osteoclastogenesis.

Authors:  Tiziana Franceschetti; Neha S Dole; Catherine B Kessler; Sun-Kyeong Lee; Anne M Delany
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

10.  Evaluation of Muscle microRNA Expression in Relation to Human Peripheral Insulin Sensitivity: A Cross-Sectional Study in Metabolically Distinct Subject Groups.

Authors:  Dennis Dahlmans; Alexandre Houzelle; Johanna A Jörgensen; Esther Phielix; Lucas Lindeboom; Matthijs K C Hesselink; Patrick Schrauwen; Joris Hoeks
Journal:  Front Physiol       Date:  2017-09-21       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.